MedTrace Logo

A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY

NCT02910440 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2020-05-13

No results posted yet for this study

Summary

The primary objective of this Phase 2 Study was to compare the safety of 3 liter(L) and 4 liter(L) split dose DCL-101 to split dose 4L GoLYTELY in patients preparing for colonoscopy, with secondary objectives to assess tolerability and bowel cleansing efficacy.

Conditions

  • Bowel Preparation Before Colonoscopy

Interventions

DRUG

DCL-101 vs Golytely

Sponsors & Collaborators

  • Dark Canyon Laboratories, LLC

    lead INDUSTRY

Principal Investigators

  • Philip N Calvillo · Alimentiv Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910440 on ClinicalTrials.gov